← FDA Drug Approvals (Drugs@FDA)
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: P AND L · Approved 2019-01-25
Drug application
- FDA Application #
ANDA207597- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
- Generic name
- Diphenhydramine Hydrochloride
- Active ingredients
- DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- P AND L
- First approval
- 2019-01-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown